TMCnet News
Research and Markets: H5N1 Infection (Avian Influenza) Pipeline Review 2015 - 42 Companies & 59 Drug ProfilesResearch and Markets (http://www.researchandmarkets.com/research/gqwgst/h5n1_infection) has announced the addition of the "H5N1 Infection (Avian Influenza) - Pipeline Review, H1 2015" report to their offering. This report provides comprehensive information on the therapeutic development for H5N1 Infection (Avian Influenza), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for H5N1 Infection (Avian Influenza) and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitve advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development
For more information visit http://www.researchandmarkets.com/research/gqwgst/h5n1_infection
View source version on businesswire.com: http://www.businesswire.com/news/home/20150731005638/en/ |